Epilogue On Esperion Therapeutics (Rating Downgrade)
Source: SeekingAlpha
2026-05-16 08:15:00 ET
...
Read the full article on Seeking Alpha
For further details see:
Epilogue On Esperion Therapeutics (Rating Downgrade)
Esperion Therapeutics Inc.
NASDAQ: ESPR
ESPR Trading
-0.16% G/L:
$3.13 Last:
2,897,365 Volume:
$3.13 Open:
ESPR Latest News
May 26, 2026 08:00:00 am
Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026
May 13, 2026 08:00:00 am
Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026
May 07, 2026 09:51:31 am
Esperion Therapeutics Inc. (NASDAQ: ESPR) Near Top of Volume Charts in Thursday Trading
ESPR Stock Data
$804,448,466
234,999,359
0.16%
70
N/A
Pharmaceuticals
Healthcare
US
Ann Arbor
